SLC7A11 and acute myeloid leukemia: Furthermore, APR-246 synergised with other ferroptosis inducers in vitro, and while it was ineffective as a single agent in vivo, it effectively reduced tumour burden in mice engrafted with SLC7A11 KD AML cells [107].